Mangoceuticals, Inc.

NasdaqCM MGRX

Mangoceuticals, Inc. Goodwill for the quarter ending September 30, 2024: USD 0.00

Mangoceuticals, Inc. Goodwill is USD 0.00 for the quarter ending September 30, 2024. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

NasdaqCM: MGRX

Mangoceuticals, Inc.

CEO	Mr. Jacob D. Cohen
IPO Date	March 21, 2023
Location	United States
Headquarters	15110 North Dallas Parkway
Employees	3
Sector	Health Care
Industries Telehealth Pharmaceuticals

Description

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Key trends

Past 5 years